Haleon plc: Board
Changes
5
December 2024: Haleon plc (the
"Company" or "Haleon") (LSE/NYSE: HLN) today announces the
following changes to the Board.
Following the reduction of Pfizer
Inc.'s shareholding in Haleon plc below 20%, and in line with the
Pfizer Relationship Agreement with Haleon plc, David Denton,
Non-Executive Director and
representative of Pfizer Inc., stepped down
from the Board on 4 December 2024.
Bláthnaid Bergin has been appointed
as an independent Non-Executive Director and will join the Haleon
Board on 24 February 2025.
Bláthnaid Bergin brings financial leadership
and strategic planning experience from a variety of consumer-facing
businesses. Bláthnaid is currently the Chief Financial Officer of J
Sainsbury plc, where she has played a pivotal role in driving the
company's financial strategy and operational efficiency
initiatives. Prior to joining Sainsbury's, Bláthnaid held senior
finance leadership and international positions at Aviva, RSA and GE
working across Europe, Asia and Australia. She is a Chartered
Accountant. Bláthnaid was previously Non-Executive Director, Chair
of the Audit Committee and Senior Independent Director for Artemis
Alpha Investment Trust.
Sir
Dave Lewis, Haleon's Chair commented: "On
behalf of the Board, I would like to thank Dave for his insights
and contributions to the Board's discussions. We wish him all the
very best for the future. I would like to welcome Bláthnaid to
Haleon. With her strong track record of financial leadership and
transformation from multiple consumer-facing businesses, Bláthnaid
brings a wealth of relevant skills and experience to the
Board."
The Company confirms that there is no further
information to be disclosed under the requirements of UKLR 6.4.6R
and 6.4.8R.
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global
leader in consumer health, with a purpose to deliver better
everyday health with humanity. Haleon's product portfolio spans
five major categories - Oral Health, Pain Relief, Respiratory
Health, Digestive Health and Other, and Vitamins, Minerals and
Supplements (VMS). Its long-standing brands - such as Advil,
Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident,
parodontax and Centrum - are built on trusted science, innovation
and deep human understanding.
For more information, please
visit www.haleon.com.